Clinical trials

Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
Health

Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study

By Jonel Aleccia and The Associated Press
May 12, 2025
A woman wearing a head wrap gets a vaccine from a masked doctor
Health

Early mRNA vaccine trial results show potential breakthrough in fighting one of the deadliest cancers

By
February 27, 2025
Cancer vaccination, conceptual illustration
Health

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

By
February 7, 2025
A young woman undergoes a brain scan.

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

By
February 6, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
Health

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

By Bloomberg and Gerry Smith
January 31, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403.
Health

Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.

By
January 11, 2025
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in overall survival in people with germline BRCA-mutated (gBRCAm), HER2-negative high-risk early breast cancer, 2024 clinical trial data suggest.
Health

Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows

By
December 20, 2024
Merck snags Chinese obesity drug in nearly $2 billion deal
Tech

Merck snags Chinese obesity drug in nearly $2 billion deal

By Robert Langreth and Bloomberg
December 19, 2024
Close-up of a patient administering a dose of Zepbound (tirzepatide)
Health

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

By
December 4, 2024
Health care CFOs look beyond cutting costs to juice profitability 
Newsletters

Health care CFOs look beyond cutting costs to juice profitability 

By
July 26, 2024
Saundra Pelletier, CEO of Evofem Biosciences.
Magazine

Birth control fail: Why American women can’t have better contraceptives in 2023

By
April 5, 2023
Medical doctor giving injection to make antibody for coronavirus
Health

The business of clinical trials is booming. Private equity has taken notice

By Rachana Pradhan and Kaiser Health News
December 2, 2022
People walk by Pfizer building in NYC
International

Pfizer pauses clinical trials in Russia, says it will continue to send drugs to patients

By Riley Griffin and Bloomberg
March 14, 2022
Gloved hand holding pills in front of Sanofi corporate logo
Health

Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion

By
January 7, 2022

Most Popular